Search
HomeBusiness

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

NY Times
NY Times

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”  » mehr lesen

NY Times
NY Times
Previous article
Southwest Stole Christmas. It Still Has Superfans.
Next article
Which Electric Vehicles Qualify for Federal Tax Credits?

Similar Articles

Tottenham Hotspur Owner Joe Lewis Is Charged in U.S. With Insider Trading

Business NY Times -
Federal prosecutors in Manhattan accused the British billionaire of illegally funneling nonpublic information to associates to trade on.  » mehr lesen

How Travelers Can Navigate Flight Cancellations and Delays

Business NY Times -
Advocating for yourself after an airline delay or cancellation can be challenging and confusing. Here’s how to best achieve the result you want —...

Most Popular

Copyright @ Home Business Factor | Created with ♥ in North Carolina